Wulff BS - Search Results

1

Lipid Embolism in Obese Göttingen Minipigs.

Viuff BM, Straarup EM, Nowak J, Morgills L, Skydsgaard M, Sjögren I, Wulff BS, Christoffersen BØ. Viuff BM, et al. Among authors: wulff bs. Toxicol Pathol. 2020 Feb;48(2):379-392. doi: 10.1177/0192623319880464. Epub 2019 Oct 23. Toxicol Pathol. 2020. PMID: 31645215

2

The effect of fatty diacid acylation of human PYY_3-36 on Y₂ receptor potency and half-life in minipigs.

Østergaard S, Paulsson JF, Kofoed J, Zosel F, Olsen J, Jeppesen CB, Spetzler J, Ynddal L, Schleiss LG, Christoffersen BØ, Raun K, Sensfuss U, Nielsen FS, Jørgensen R, Wulff BS. Østergaard S, et al. Among authors: wulff bs. Sci Rep. 2021 Oct 27;11(1):21179. doi: 10.1038/s41598-021-00654-3. Sci Rep. 2021. PMID: 34707178 Free PMC article.

3

Kisspeptin-52 partially rescues the activity of the hypothalamus-pituitary-gonadal axis in underweight male rats dosed with an anti-obesity compound.

Bolze F, Williams H, Bhuwania R, Egecioglu E, Bloem E, Paulsson JF, Pedersen MØ, Broadmeadow A, Chesher CJ, Moore EL, Skydsgaard M, Galle PS, Dalgaard M, Wulff BS, Tena-Sempere M, Andersen LW. Bolze F, et al. Among authors: wulff bs. Toxicol Appl Pharmacol. 2020 Oct 1;404:115152. doi: 10.1016/j.taap.2020.115152. Epub 2020 Jul 26. Toxicol Appl Pharmacol. 2020. PMID: 32726590

4

Novel α-MSH analog causes weight loss in obese rats and minipigs and improves insulin sensitivity.

Fosgerau K, Raun K, Nilsson C, Dahl K, Wulff BS. Fosgerau K, et al. Among authors: wulff bs. J Endocrinol. 2014 Jan 8;220(2):97-107. doi: 10.1530/JOE-13-0284. Print 2014 Feb. J Endocrinol. 2014. PMID: 24204009 Free PMC article.

5

Metabolism of peptide YY 3-36 in Göttingen mini-pig and rhesus monkey.

Olsen J, Kofoed J, Østergaard S, Wulff BS, Nielsen FS, Jorgensen R. Olsen J, et al. Among authors: wulff bs. Peptides. 2016 Apr;78:59-67. doi: 10.1016/j.peptides.2016.01.010. Epub 2016 Jan 14. Peptides. 2016. PMID: 26774588

6

Increase of neuronal histamine in obese rats is associated with decreases in body weight and plasma triglycerides.

Malmlöf K, Golozoubova V, Peschke B, Wulff BS, Refsgaard HH, Johansen PB, Cremers T, Rimvall K. Malmlöf K, et al. Among authors: wulff bs. Obesity (Silver Spring). 2006 Dec;14(12):2154-62. doi: 10.1038/oby.2006.252. Obesity (Silver Spring). 2006. PMID: 17189541 Free article.

7

Y5 receptor signalling counteracts the anorectic effects of PYY3-36 in diet-induced obese mice.

Shi YC, Ip CK, Reed F, Sarruf DA, Wulff BS, Herzog H. Shi YC, et al. Among authors: wulff bs. J Neuroendocrinol. 2017 Oct;29(10). doi: 10.1111/jne.12483. J Neuroendocrinol. 2017. PMID: 28485050

8

Rational Development of Stable PYY_3-36 Peptide Y₂ Receptor Agonists.

Poulsen C, Pedersen MØ, Wahlund PO, Sjölander A, Thomsen JK, Conde-Frieboes KW, Paulsson JF, Wulff BS, Østergaard S. Poulsen C, et al. Among authors: wulff bs. Pharm Res. 2021 Aug;38(8):1369-1385. doi: 10.1007/s11095-021-03077-x. Epub 2021 Jul 16. Pharm Res. 2021. PMID: 34272643

9

The Design of a GLP-1/PYY Dual Acting Agonist.

Østergaard S, Paulsson JF, Kjaergaard Gerstenberg M, Wulff BS. Østergaard S, et al. Among authors: wulff bs. Angew Chem Int Ed Engl. 2021 Apr 6;60(15):8268-8275. doi: 10.1002/anie.202016464. Epub 2021 Mar 1. Angew Chem Int Ed Engl. 2021. PMID: 33448563

10

Design of Y₂ Receptor Selective and Proteolytically Stable PYY_3-36 Analogues.

Østergaard S, Kofoed J, Paulsson JF, Madsen KG, Jorgensen R, Wulff BS. Østergaard S, et al. Among authors: wulff bs. J Med Chem. 2018 Dec 13;61(23):10519-10530. doi: 10.1021/acs.jmedchem.8b01046. Epub 2018 Nov 20. J Med Chem. 2018. PMID: 30399314

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

64 results

Search Page